Salomon Azoulay, Chief Medical Officer at MBX Biosciences, Inc. (MBX), sold 370 shares at $65.77 ($24K) on 2026-08-04, disclosed to the SEC on 2026-08-05.
Open-market sale of $24k MBX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |